Work

Abstract LB-89: Clinical combination of the MEK inhibitor GDC-0973 and the PI3K inhibitor GDC-0941: A first-in-human phase Ib study in patients with advanced solid tumors

Year: 2011

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2011-lb-89

Authors: Johanna Bendell, Patricia LoRusso, Eunice Kwak, Susan Pandya, Luna Musib, Cheryl Jones, Alex De Crespigny, Marcia Belvin, Meghan McKenzie, Mary R. Gates, Iris Chan, Geoffrey Shapiro

Institutions: Sarah Cannon, The Barbara Ann Karmanos Cancer Institute, Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2033686679

Cites:

Cited by: 7

Related to: 10